1. MARAPHARM
Watch us grow!

2. MARAPHARM Company Overview CSE: MDM OTCQB: MRPHF FSE: 2M0
Marapharm is a publically traded company focused on the health and wellness industry, including medical and recreational cannabis products.
Our research and development partners, work in the field of maximizing the purity and yield of cannabis, as well as the development of a prescribed dosage formula for medical patients. This provides us with a competitive advantage in this sector.

3. The Challenges that face this industry.
MARAPHARM
The Good, the Bad and the Solutions
The Challenges that face this industry.
Wholesale/retail price trending down
An average of $1,641 per pound wholesale (Forbes.com)
Operational costs increasing
Operational inefficiencies, electricity, water, taxes, fees and permits
Pesticide and nutrient recalls
Poor farming practices and poor management techniques
Insufficient capital for expansion and stabilization
Investors still hesitant
Banking and Financing still difficult

4. The cannabis market. MARAPHARM The Good, the Bad and the Solutions
Colorado hits $1 Billion in 10 months
2 years for Washington to achieve $1Billion
8 States and District of Columbia have now legalized recreational cannabis
29 States and D.C now have some form of decriminalization, mostly medical in nature
Adult recreational and medicinal cannabis usage and related revenue are trending up
In the US, The Tax Foundation estimates that the entire Cannabis industry (both legal and illegal) could be worth $45 billion
In Canada, Deloitte’s survey estimates the retail marijuana industry to be between $4.9 and $8.7 billion.
In Europe many countries are also looking to legalize cannabis

5. Marapharm’s Solution to the Challenges
The Good, the Bad and the Solutions
Marapharm’s Solution to the Challenges
The cultivation technology we will be implementing has:
Increased Yield- Thereby being able to absorb potential lower wholesale pricing.
Lower operating costs - Resulting in increased profit.
No need for use of fungicides, pesticides or artificial nutrients -
Creating a creating a clean product and reducing the chance of product recall.

6. Marapharm Las Vegas MARAPHARM Watch us Grow
7.1 acres purchased in APEX North cannabis industrial park
6 licenses for cultivation, 3 for recreational cultivation and 3 medical (2 cultivation, 1 production)
Phase I – two 5,000 sq ft starter buildings (already purchased and on-site)
Phase II – 300,000 sq ft of cannabis cultivation and production (largest in the state)
With 55+ Million tourists a year, Las Vegas is poised to be the largest single city cannabis market in the United States.
Built to suit

7. Marapharm Washington MARAPHARM Watch us Grow
13.2 Acres including land and buildings under contract with deposit.
Tier 3 Cultivation and Processing tenant currently producing $30K revenue per month in 5% of the building
Excellent opportunity to create a cannabis ‘campus’ utilizing ALL buildings and adding additional cultivation licenses.
Includes revenue generating tenants not in the cannabis business

8. Marapharm California MARAPHARM Watch us Grow
California will be one of the largest cannabis markets in the country
2 Parcels of land: (a) 1.22 acres of land and (b) 7.2 acres
Includes plans for (a) 2-Story 30,000 sq ft cultivation and processing facility with CUP approval and 2 licenses and (b) 5 building cultivation and processing facility
One of the first approved Medical Delivery Service licenses already purchased

9. Marapharm Canada MARAPHARM Watch us Grow
Canada is on the verge of being the first G13 country to legalize cannabis
MMPR application with Health Canada has passed the Security Clearance Stage
Leased 11 acre site

10. MARAPHARM Grow with Us! Trading Symbol: CSE: MDM FSE: 2M0 OTCQB: MRPHF
As of June 29th 2017
Number of Outstanding Listed Securities: 80,842,936
Working Capital: ~$5,000,000
Options Issued: 6,875,000
Warrants: 8,747,000
Fully Diluted Share Capital: 100,464,936
52 week Hi Low:
Currently Trading: $1.09 (as of 7/13/2017)
Marapharm holds 15 million shares and warrants in Veritas Pharma Inc (VRT.CSE)
Auditor: WDM Chartered Professional Accountants

11. MARAPHARM Warrant Term Sheet- Marapharm Ventures Inc.
Issuer: Marapharm Ventures Inc.
About: Marapharm has holdings in both the US and Canadian legal cannabis markets, with investments being made in Nevada, Washington, California and British Columbia. Cannabis sales in North America topped 6.7 billion dollars in 2016, the market is still in its infancy and is expected to continue to grow.
Investment: Warrant
Offering: 10 cents per warrant for gross proceeds of up to $8 million CDN, excersisable into one common share for the price of $2.90 per share for a period of 3 years from the date of closing.
Unit Size: Discretionary
Fees: Up to 10% cash and or a combination of cash and warrants
Closing: May be done in tranches intended to close by July 31st, 2017
Term: 3 years
Use of Funds: Proceeds will be utilized for development and corporate purposes
Condition: Subject to regulatory filing
Stock Markets: Marapharm intends to apply to list the warrants on the CSE, OTCQB and or the FSE upon the expiry of the 4 month hold period and subject to compliance with the policies of the stock exchanges
Other: This offering of warrants is unique. There is no immediate dilution and it provides an opportunity for subscribers to hedge and leverage an investment with a 3 year open window into the future of the company. The warrants would provide Marapharm with an additional $232 million if all warrants are exercised.
Contact:

12. Funding requirements and projections
MARAPHARM
Grow With Us!
Funding requirements and projections
Washington $10 million
Use of funds: Completion of real estate transaction, renovation of the cultivation facility, construction of processing facility and construction of Research and development Lab.
Potential revenue: Approx. $4.8 + million per year
Nevada $5.5 million
Use of funds: Construction of the two 5,000 sq’ starter buildings.
Potential revenue: Approx. $9.9 million per year
California $10 million
Use of funds: Purchase of two properties, construction of a 29,193 sq’ cultivation and processing facility, as well as, a second 102,000 sq’ cultivation and processing facility .
Potential revenue: Approx. $102 million per year

13. MARAPHARM Grow With Us! The Marapharm Team The Board
Linda Sampson (CEO) - A business start-up professional, sales professional, designer, marketer and developer.
Corey Klassen (CFO) - With a strong financing background and more than 20 years of
business development management experience for major financial institutions, mortgage brokerage firms and publicly traded companies.
Brian Lovig (President) - Brian has been a longtime entrepraneur and investor. A fervent supporter of free enterprise. Brian has also been the host of Right Edition, an online political show, for the past seven years.
Yari Nieken Yari has a wide range of public company and capital market
Experience. He is founder and president of Foremost Capital Inc.,
An exempt market dealer.

14. MARAPHARM Grow With Us! The Marapharm Team Advisory Board
Brad Dixon - Selected as one of "America's Leading Lawyers for Business" (Idaho) by Chambers USA.
Ron Cannan- Former member of parliament and 30 years of small business and
corporate experience.
Industry Advisors
Kurt Keating- Kurts company was a two times Cannabis Cup winner. He is an expert In various methods of cannabis cultivation.

15. Watch us grow… ... Grow with us? MARAPHARM In Conclusion
Contact us: or 1 (250)